However, venlafaxine is not recommended in the UK as a first-line treatment because of evidence suggesting its risks may outweigh benefits, and it is specifically discouraged in children and adolescents.
Venlafaxine, an antidepressant with a different mechanism of action, may be modestly more effective than SSRIs.